CAMP4 THERAPEUTICS CORP

5AM Partners Buys 7.6% of Camp4 Therapeutics’ Shares in Pre‑Funded Warrants, Fueling Investor Confidence Amid Rising Stock Price

5AM Partners buys 3.2M pre‑funded warrants in Camp4 Therapeutics, signaling confidence in its RNA‑based pipeline and a potential dilution risk as shares rise.

CAMP4 THERAPEUTICS CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

05/08/2026, 23:55

3 minutes to read

Director Young Richard A’s $1.65 Share Buy Fuels Optimism for Camp4 Therapeutics’ Rapid Growth Trajectory

Camp4 Insider Buying Signals Confidence – Director Richard A. adds 16,378 shares at $1.65, boosting a 180% rally and supporting the CMP‑002 pipeline.

CAMP4 THERAPEUTICS CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

05/08/2026, 23:30

3 minutes to read